MedPeer, Inc. (6095) AI Stock Analysis

• Market Cap: ¥15.34B
• Dividend Yield: 0.65%
• Average Volume (3M): 106.53K
• Price to Earnings (P/E): 10.2
• Beta (1Y): 0.92
• Revenue Growth: -17.86%
• EPS Growth: 133.08%
• Country: JP
• Employees: 489
• Sector: Healthcare
• Sector Strength: 53
• Industry: Medical - Healthcare Information Services
• EPS (TTM): 0.44
• Shares Outstanding: 22,010,330
• 10 Day Avg. Volume: 125,010
• 30 Day Avg. Volume: 106,533
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥770.00
• Price Target Upside: 10.47% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1

• Rating: 71 Outperform
• Price Target: ¥770.00 ▲(10.47% Upside)

MedPeer, Inc.'s overall stock score is driven primarily by its strong financial performance, characterized by robust revenue growth and efficient cost management. The valuation is reasonable, offering a fair P/E ratio and a modest dividend yield. Technical analysis indicates short-term bearish momentum, but the stock maintains a long-term uptrend. The absence of earnings call and corporate events data limits further insights.

MedPeer, Inc. Business Overview & Revenue Model

Company Description

MedPeer, Inc. (6095) is a Japanese healthcare technology company that operates a medical platform designed to facilitate information exchange and collaboration among healthcare professionals. The company primarily operates in the digital healthcare sector, offering services such as a peer-to-peer network for doctors, which allows them to share experiences and insights on medical cases and treatments. MedPeer also provides health-related information and services to patients and the broader public.

How the Company Makes Money

MedPeer, Inc. generates revenue through multiple channels, primarily focusing on subscription and advertising models. The company's platform offers premium subscription services to healthcare professionals who seek access to exclusive content, detailed medical case studies, and advanced networking tools. Additionally, MedPeer earns revenue from advertising by partnering with pharmaceutical companies and other healthcare-related businesses to promote products and services on their platform. These partnerships allow MedPeer to leverage its professional network to provide targeted advertising solutions. Furthermore, the company may generate income through sponsored content and collaborations with medical institutions for research and development projects.

MedPeer, Inc. Financial Statement Overview

Summary

MedPeer, Inc. exhibits solid financial performance with strong revenue and profit growth, efficient cost management, and low leverage. The income statement and balance sheet reflect overall financial health. However, cash flow management needs attention to support long-term growth and operational resilience.

Income Statement

MedPeer, Inc. demonstrates strong revenue growth with a notable increase from 2022 to TTM 2024. The gross profit margin is robust, indicating efficient cost management. While the net profit margin is healthy, the slight decline in EBIT margin suggests increasing operational expenses. Overall, the income statement reflects a solid financial performance with room for margin improvement.

Balance Sheet

The balance sheet is strong with a low debt-to-equity ratio, indicating financial stability and low leverage risk. The equity ratio highlights a solid asset base supported by equity. Return on Equity (ROE) is commendable, showing efficient use of shareholder funds. However, the slight increase in total liabilities requires monitoring to ensure continued financial health.

Cash Flow

Cash flow analysis shows mixed results. The operating cash flow has significantly increased, demonstrating enhanced cash-generating capability. Free cash flow has grown, but the absence of recent data limits a complete trend analysis. The ratio of operating cash flow to net income is favorable, suggesting good cash conversion. Continued focus on sustaining cash flow growth is necessary.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	13.41B	14.95B	14.54B	8.45B	7.44B	5.31B
Gross Profit	6.16B	6.87B	6.87B	5.03B	4.85B	3.51B
EBITDA	1.76B	3.01B	1.87B	1.30B	1.98B	1.27B
Net Income	1.71B	1.48B	617.68M	812.39M	1.29B	725.97M
Balance Sheet
Total Assets	14.81B	15.55B	15.16B	9.35B	8.54B	7.13B
Cash, Cash Equivalents and Short-Term Investments	7.16B	7.28B	5.39B	6.14B	5.70B	4.70B
Total Debt	2.90B	3.16B	3.81B	179.12M	136.32M	202.90M
Total Liabilities	5.02B	6.10B	6.57B	1.49B	1.56B	1.55B
Stockholders Equity	9.80B	9.45B	8.30B	7.59B	6.71B	5.35B
Cash Flow
Free Cash Flow	0.00	1.63B	494.10M	691.01M	1.11B	758.87M
Operating Cash Flow	0.00	1.89B	600.07M	853.23M	1.36B	930.30M
Investing Cash Flow	0.00	1.27B	-5.01B	-422.88M	-345.39M	-469.23M
Financing Cash Flow	0.00	-1.27B	3.67B	7.08M	-15.44M	1.11B

MedPeer, Inc. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 697.00
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6095, the sentiment is Positive. The current price of 697 is above the 20-day moving average (MA) of 696.50, below the 50-day MA of 723.64, and above the 200-day MA of 570.15, indicating a neutral trend. The MACD of -5.11 indicates Negative momentum. The RSI at 42.12 is Neutral, neither overbought nor oversold. The STOCH value of 38.89 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:6095.

MedPeer, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
3649	79 Outperform	¥21.41B	18.68		1.91%	-6.29%	-22.25%
4320	73 Outperform	¥12.79B	12.15		2.41%	7.79%	38592.95%
3939	72 Outperform	¥24.71B	24.29		1.25%	13.39%	12.00%
6095	71 Outperform	¥15.34B	10.17		0.65%	-17.86%	133.08%
Sector *	51 Neutral	$7.95B	-0.40	-41.67%	2.21%	22.29%	-1.85%
4263	45 Neutral	¥15.02B	―		―	35.15%	16.85%
3902	43 Neutral	¥23.28B	4,465.71		1.09%	-0.58%	-260.22%

MedPeer, Inc. Corporate Events

MedPeer, Inc. Announces Amendments to MBO and Tender Offer Recommendations

MedPeer, Inc. has announced amendments to its previously issued notices regarding a Management Buyout (MBO) and a recommendation to tender shares. The company has resolved to support the tender offer initiated by NMT, Inc., which includes extending the tender offer period to provide shareholders with more time to decide. This decision is aimed at enhancing corporate value and ensuring fairness in the transaction, reflecting MedPeer’s commitment to its shareholders and corporate governance.

MedPeer Extends Tender Offer Period Amid Stable Share Price

MedPeer, Inc. announced an extension of the tender offer period by NMT, Inc. for its share certificates, now totaling 60 business days. The tender offer price remains unchanged at 700 yen per share, and no insider information affecting investor decisions has been reported. The settlement date is set for August 15, 2025, and the company has clarified that shares not tendered will be acquired by the Tender Offeror if the offer is successful.

MedPeer, Inc. Announces Extension of NMT, Inc.’s Tender Offer

MedPeer, Inc. has announced an amendment to the ongoing tender offer by NMT, Inc. for its shares. The tender offer, which began on May 15, 2025, has been extended to August 7, 2025, to provide shareholders more time to consider their participation. This extension aims to increase the likelihood of completing the tender offer, impacting MedPeer’s shareholder dynamics and potentially its market positioning.

MedPeer, Inc. Announces Extension of NMT, Inc.’s Tender Offer Period

MedPeer, Inc. has announced an amendment to the ongoing tender offer by NMT, Inc. for its share certificates. The tender offer period has been extended by 10 business days, now concluding on July 24, 2025, to provide shareholders additional time to consider their options. This move aims to enhance the likelihood of the tender offer’s completion, reflecting a strategic effort by NMT, Inc. to secure its acquisition of MedPeer, Inc.

MedPeer, Inc. Extends Tender Offer Period Amid MBO Amendments

MedPeer, Inc. announced amendments to its previously released notice concerning a Management Buyout (MBO) and a recommendation to tender, involving an extension of the tender offer period by NMT, Inc. The extension aims to provide shareholders with more time to consider tendering their shares, potentially impacting the company’s shareholder structure and market presence.

MedPeer, Inc. Extends Tender Offer Period Amid MBO Amendments

MedPeer, Inc. announced amendments to its previously declared management buyout (MBO) and tender offer process, initiated by NMT, Inc., aimed at delisting MedPeer’s shares. The tender offer period has been extended to provide shareholders more time to decide on tendering their shares, with the period now concluding on July 9, 2025. This strategic move is intended to increase the likelihood of a successful tender offer, although the tender price remains unchanged for now.

MedPeer, Inc. Extends Tender Offer Period Amid NMT Acquisition Bid

MedPeer, Inc. has announced an amendment to the ongoing tender offer by NMT, Inc. for its share certificates. The tender offer period has been extended by 10 business days, now concluding on July 9, 2025, to give shareholders more time to consider their participation. This extension aims to increase the likelihood of the tender offer’s completion, although the tender offer price remains unchanged for now.

MedPeer Announces Amendments to MBO Tender Offer Notice

MedPeer, Inc. announced amendments to its previously published notice regarding the implementation of a Management Buyout (MBO) and a recommendation to tender shares. The amendments clarify the intentions of Mr. Yo Iwami, a significant shareholder, to release collateralized shares and participate in the tender offer. The company plans to finance the tender offer through a bank loan from MUFG Bank and an equity investment, with the acquired shares and certain company assets pledged as collateral.

MedPeer, Inc. Announces Management Buyout and Delisting Plans

MedPeer, Inc. has announced a management buyout (MBO) involving a tender offer by NMT, Inc. to purchase its common shares, with the intention of taking the company private and delisting its shares. The board has expressed support for the tender offer, recommending shareholders to tender their shares, while leaving stock acquisition rights holders to decide independently. This move is expected to retract MedPeer’s plan for compliance with continued listing criteria, impacting its market presence and shareholder dynamics.

NMT, Inc. Launches Tender Offer for MedPeer, Inc. Shares

NMT, Inc. has announced a tender offer to acquire all shares of MedPeer, Inc., aiming to delist the company from the Tokyo Stock Exchange. This move, characterized as a management buyout, will see NMT’s founder, Yo Iwami, maintaining involvement in MedPeer’s operations, potentially impacting stakeholders by consolidating control and potentially reshaping the company’s strategic direction.

MedPeer, Inc. Reports Decline in Financial Results Amidst Market Challenges

MedPeer, Inc. reported a decline in its consolidated financial results for the six months ended March 31, 2025, with net sales and operating profits experiencing significant decreases compared to the previous year. Despite the downturn in sales, the company saw a substantial increase in profit attributable to owners of the parent, indicating improved efficiency or cost management. The forecast for the fiscal year ending September 30, 2025, suggests further declines in sales and profits, posing challenges for the company’s future growth and market positioning.

MedPeer, Inc. Supports Tender Offer and Plans Delisting

MedPeer, Inc. has announced its support for a tender offer by NMT, Inc. to purchase its common stock and stock acquisition rights, with plans to delist the company shares following the offer. This decision leads to the retraction of MedPeer’s previously announced compliance plan for continued listing criteria, indicating a strategic shift in the company’s market approach and potential implications for its shareholders.

MedPeer Revises Dividend Forecast Amid Tender Offer Plans

MedPeer, Inc. announced a revision to its dividend forecast for the fiscal year ending September 2025, deciding not to distribute year-end dividends. This decision aligns with the company’s support for a tender offer by NMT, Inc., which aims to take MedPeer private and delist its shares. The tender offer price assumes no year-end dividends, reflecting a strategic shift in the company’s financial planning and shareholder returns policy.